In his opening remarks, B. L. Johnson (NIOSH) listed four objectives for this symposium. These were: (1) to foster direct exchange between scientists who are active in glycol ether research; (2) to summarize the current state of knowledge on glycol ether toxicity; (3) to identify future research needs; and (4) to identify actions needed to protect the health of workers exposed to glycol ethers. The symposium was productive in all these areas, involving investigators from government, academic, and industrial laboratories. Speaking in behalf of the Chemical Manufacturers Association Special Project Panel on Glycol Ethers, J. P Lyon (ICI Americas) described the Toxicology Research Task Group's testing program. Data developed as part of this industry initiative were presented throughout this symposium.
.
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R. L. Smith (Eastman Chemical Products, Inc.) reviewed the basic uses of ethylene glycol ethers and ether esters, especially in various surface coatings. The combination of mild odor, low evaporation rate, good solvent and coupling activity, flow and leveling qualities, blush resistance ('blushing" is the formation of a hazy finish due to absorption of atmospheric moisture) and solvent release (the ability of the solvent to escape from beneath the surface film as a coating dries) were cited as a few of the factors which lead to the unique position occupied by this class of compounds. Many of the specific uses of ethylene glycol ethers are based on a combination of these characteristics and were derived through experience over many years. Product reformulation to replace one material with another therefore cannot be a simple one-for-one exchange and replacement of glycol ethers may be difficult in some applications. Others, including EGME, were not identified by this system as possessing unique developmental toxicity.
A short-term in vitro assay was reported by R. L. Schuler (NIOSH). The results of these tests confirmed the recognized embryotoxicity of EGME, EGdiME, and EGEE and suggested that mono-and dimethyl ether derivatives of diethylene and triethylene glycol should also be evaluated in detail. In similar in vivo studies, Doe reported that neither PGME nor diEGME had adverse effects on the outcome of pregnancy.
An unexpected observation in the in vivo assay reported by Schuler was evidence that ethylene glycol (EG) might itself be embryotoxic. Subsequent EG studies, reported by J. C. Lamb (National Institute for Environmental Health Sciences), in fact confirmed the teratogenicity of EG. These studies involved both conventional teratology in mice and rats, as well as a new screening assay in which breeding pairs of mice are cohabited for up to 120 days while being exposed to the chemical in the drinking water. Remarkably similar skeletal defects were reported in both species and in both experimental protocols. The continuous breeding protocol was also reported by Lamb to reveal antifertility effects of EGEE not only in males, as would have been predicted, but also in females.
Studies of the testicular toxicity of a large number of glycol ethers were summarized by K. Nagano (Japan Bioassay Laboratory), whose 1979 publication stimulated many of those in attendance to investigate the glycol ethers. Declining testicular toxicity with increasing substituent alkyl chain length was revealed by these studies, as was the molar equivalence of two acetates (EGMEA and EGEEA) with their corresponding glycol ethers (EGME and EGEE showing that cleavage of the ether linkage occurs as a minor metabolic pathway and documented that urinary excretion of ethoxyacetic acid and its glycine conjugate accounts for the majority of an administered dose. PGME, on the other hand, was shown by Miller to be demethylated and excreted in urine primarily as propylene glycol. Foster demonstrated on the histologic level that the in vivo effects of methoxyacetic acid parallel those of EGME and showed that inhibition of alcohol dehydrogenase protected against the testicular toxicity of EGME, while inhibition of aldehyde dehydrogenase did not prevent testicular toxicity.
The ability of glycol ethers to penetrate the skin in toxic amounts has long been recognized. That rats can absorb teratogenic doses of EGEE and EGEEA by this route was reported by B. D. Hardin (NIOSH). Quantitative studies of skin penetration by various glycol ethers were presented by D. Guest (Eastman Kodak Co.) and P Dugard (Imperial Chemical Industries, PLC). Radiolabeled EGEEA and EGPEA were tested in beagle dogs by Dr. Guest, who noted very similar rates of percutaneous absorption. Dugard employed an in vitro human skin preparation in which he was able to determine with precision the kinetics of skin penetration. In both the ethylene and diethylene glycol series, the relative rate of absorption declined from methyl to ethyl to butyl ether derivatives. Diethylene glycol ethers were absorbed more slowly than the corresponding ethylene glycol ethers.
The acute and subehronic toxicity of EGEE, EGPE and EGBE was reviewed by C. C. Conaway (Texaco, Inc.), G. V Katz (Eastman Kodak Co.) and T. Tyler (Union Carbide Corporation). Reviews focused on toxic effects and target organ specificity of these glycols (kidneys, liver, hematopoietic system and red blood cells). For Questions of a more immediate and practical nature face the many users of glycol ethers. Exposures must be controlled to acceptable levels. Where exposure controls are not feasible substitutes will be necessary. Alternative solvents with appropriate physical, chemical, and solvent properties but lacking the reproductive toxicity of EGME or EGEE must be found. The growth of knowledge regarding biological activity has been rapid in the past two to three years and promises to accelerate. Studies reported at this symposium will go far toward providing a basis for the design of future studies and for making the best-informed business decisions possible on exposure or substitutions.
